Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Free Cash Flow per Share of $-0.62 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$20.92M |
|
$-47.92M |
|
$24.45M |
|
$-3.52M |
|
$82.14M |
|
$-61.22M |
|
$13.70M |
|
$-47.52M |
|
$-47.52M |
|
$-47.92M |
|
$-47.92M |
|
$-47.92M |
|
$-47.92M |
|
$-61.22M |
|
$-58.85M |
|
266.14M |
|
266.14M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$574.25M |
|
$66.47M |
|
$146.73M |
|
$720.98M |
|
$68.15M |
|
-- |
|
$306.37M |
|
$374.52M |
|
$346.46M |
|
$333.53M |
|
$346.46M |
|
266.14M |
|
| Cash Flow Statement Financials | |
$-148.35M |
|
$36.37M |
|
$-0.77M |
|
$228.81M |
|
$125.33M |
|
$-103.47M |
|
$7.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.83% |
|
-292.58% |
|
-292.58% |
|
-- |
|
-227.12% |
|
-229.02% |
|
$-163.87M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.02 |
|
0.79 |
|
114.61 |
|
-13.83% |
|
-14.37% |
|
-6.65% |
|
-13.83% |
|
$1.30 |
|
|
Free Cash Flow per Share |
$-0.62 |
$-0.56 |
|